Modulation of Tumor Cytotoxicity and Targeting Selectivity of Nanocarriers via a Dual Ligand Targeting Approach

摘要

Use of ligands to direct nanocarriers at over-expressed receptors on tumor cells is nearing clinical reality. This study demonstrates the ability to tailor nanocarriers fo match the cell receptor profile, thereby improving tumor-cell selectivity.